| 710 |
decreased |
abnormal circulating thyroxine level
(MP:0005475)
|
thyroxine
(CHEBI:30660)
|
281: Thyroxine (T4) in serum, Decreased
|
| 709 |
increased |
endocytosis
(GO:0006897)
|
lysosomal membrane
(GO:0005765)
|
1539: Endocytotic lysosomal uptake
|
| 708 |
abnormal |
chemical synaptic transmission
(GO:0007268)
|
synapse
(GO:0045202)
|
758: Hippocampal Physiology, Altered
|
| 707 |
morphological change |
brain development
(GO:0007420)
|
hippocampal formation
(UBERON:0002421)
|
757: Hippocampal anatomy, Altered
|
| 706 |
decreased |
regulation of hormone levels
(GO:0010817)
|
thyroxine
(CHEBI:30660)
|
280: Thyroxine (T4) in neuronal tissue, Decreased
|
| 705 |
decreased |
fatty acid beta-oxidation
(GO:0006635)
|
|
1528: Fatty Acid Beta Oxidation, Decreased
|
| 704 |
decreased |
testicular atrophy
(MP:0003205)
|
Testis
(FMA:7210)
|
None
|
| 703 |
decreased |
|
spermatocyte
(CL:0000017)
|
1515: Spermatocyte depletion
|
| 702 |
increased |
increased apoptosis
(MP:0006042)
|
apoptosis fated cell
(CL:0000445)
|
None
|
| 701 |
disrupted |
regulation of cell cycle
(GO:0051726)
|
cell cycle-related cyclin
(PR:000029191)
|
1505: Increase, Cell cycle disruption
|
| 700 |
increased |
positive regulation of gene expression
(GO:0010628)
|
cyclin-dependent kinase inhibitor
(PR:000000014)
|
1504: p21 (CDKN1A) expression, increase
|
| 699 |
increased |
regulation of protein modification process
(GO:0031399)
|
histone
(CHEBI:15358)
|
1503: Histone acetylation, increase
|
| 698 |
decreased |
enzyme inhibitor activity
(GO:0004857)
|
histone deacetylase 1
(PR:000008478)
|
1502: Histone deacetylase inhibition
|
| 697 |
decreased |
abnormal protein level
(MP:0008469)
|
vascular endothelial growth factor A
(PR:000017284)
|
948: reduced production, VEGF
|
| 696 |
decreased |
|
vascular endothelial growth factor A
(PR:000017284)
|
None
|
| 695 |
increased |
acute inflammatory response
(GO:0002526)
|
|
1493: Increased Pro-inflammatory mediators
|
| 694 |
increased |
cell activation involved in immune response
(GO:0002263)
|
|
1492: Tissue resident cell activation
|
| 693 |
increased |
cell activation involved in immune response
(GO:0002263)
|
tissue-resident macrophage
(CL:0000864)
|
None
|
| 692 |
increased |
cell activation involved in immune response
(GO:0002263)
|
leukocyte
(CL:0000738)
|
1494: Leukocyte recruitment/activation
|
| 691 |
increased |
acute inflammatory response
(GO:0002526)
|
Cytokine
(FMA:84050)
|
None
|
| 690 |
increased |
epithelial cell proliferation
(GO:0050673)
|
kidney tubule cell
(CL:1000507)
|
710: Increase, Regenerative cell proliferation (tubular epithelial cells)
|
| 689 |
increased |
neuropeptide hormone activity
(GO:0005184)
|
Neurokinin A
(CHEBI:80311)
|
1435: Increased neurokinin A (NKA) by neuronal cells
|
| 688 |
increased |
neuropeptide hormone activity
(GO:0005184)
|
Calcitonin gene-related peptide 1
(CHEBI:80337)
|
1433: Increased CGRP, neuronal release of CGRP
|
| 687 |
decreased |
glutamate secretion
(GO:0014047)
|
glutamate(1-)
(CHEBI:14321)
|
383: Reduced, Presynaptic release of glutamate
|
| 686 |
increased |
NMDA glutamate receptor activity
(GO:0004972)
|
NMDA selective glutamate receptor complex
(GO:0017146)
|
388: Overactivation, NMDARs
|